Travel and seminars Med devices(266,469) CC(1,056,414) DNA Vac (10,073) Manufacturing(1,548) Corporate(214,689) Total=(1,549,193)
Thats not a lot of money for all the conferences over the whole group. $1,056,414 spent for bio implants(CC)
$355k in R&D for CC, $638k spent on DNA Vaccines
Total segement revenue for CC was $1,366,055 up from $78,166 in the prior corresponding half (2013)
Med device division still made a profit of $15,951, but that was down from $822,945 profit in the PCP.
A poor performance from the med sales division(thats been obvious in the quarterlys) but a good performance from bio implants
good bad or indifferent, page-39
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.80 |
Change
-0.200(1.11%) |
Mkt cap ! $341.1M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.00 | $17.75 | $46.16K | 2.581K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 122 | $17.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.91 | 32 | 2 |
View Market Depth
| Last trade - 13.54pm 15/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |